Johnson & Johnson COVID-19 vaccine shows promising results in mid-stage trials – New York Post

One dose of Johnson & Johnson’s experimental COVID-19 vaccine yielded strong immune system responses in “healthy adults” against the coronavirus in a mid-stage clinical trial, according to welcom… [+1031 chars]